Xinhua Silk Road: Guotai Junan Securities, Haitong Securities issue joint circular, disclosing merger details BEIJING, Nov. 25, 2024 /PRNewswire/ — Guotai Junan Securities Co., Ltd. and… CISION PRNewswireNovember 25, 2024
Belt and Road Youth Perspectives: Showing the Youth Power in Joint Construction of the Belt and Road BEIJING, Nov. 25, 2024 /PRNewswire/ — A news report from Haiwainet: "Belt… CISION PRNewswireNovember 25, 2024
Kuaishou Technology to Become Constituent of Hong Kong's Hang Seng Index HONG KONG, Nov. 25, 2024 /PRNewswire/ — Kuaishou Technology ("Kuaishou" or the… CISION PRNewswireNovember 25, 2024
Xinhua Silk Road: E China's Lingang promotes high-quality development with advanced manufacturing BEIJING, Nov. 25, 2024 /PRNewswire/ — Lingang Economic Development Area in Linyi… CISION PRNewswireNovember 25, 2024
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK),… CISION PRNewswireNovember 25, 2024
Press ReleaseNovo AI's Solution Boosts APRIL International's Efficiency by 400% SINGAPORE, Nov. 25, 2024 /PRNewswire/ — In just a few months, Novo… CISION PRNewswireNovember 25, 2024
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024 SAN FRANCISCO and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireNovember 25, 2024
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection SHANGHAI, Nov. 25, 2024 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")… CISION PRNewswireNovember 25, 2024
